Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - CHANGE IN WORKING CAPITAL
Change in Working Capital ESPR - Esperion Therapeutics, Inc.
13.7 M
LAST VALUE
50.35%
2 YEAR CAGR
-14.05%
5 YEAR CAGR
15.53%
10 YEAR CAGR